Search Results - "Gartlon, J."

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Further neurochemical and behavioural investigation of Brattleboro rats as a putative model of schizophrenia by Cilia, J., Gartlon, JE, Shilliam, C., Dawson, LA, Moore, SH, Jones, DNC

    Published in Journal of psychopharmacology (Oxford) (01-03-2010)
    “…Brattleboro (BRAT) rats are a mutant variant of the Long-Evans (LE) strain deficient in the neurohormone vasopressin. BRAT rats show behavioural alterations…”
    Get full text
    Journal Article
  2. 2

    Evaluation of the pro-cognitive effects of the AMPA receptor positive modulator, 5-(1-piperidinylcarbonyl)-2,1,3-benzoxadiazole (CX691), in the rat by Woolley, M. L., Waters, K. A., Gartlon, J. E., Lacroix, L. P., Jennings, C., Shaughnessy, F., Ong, A., Pemberton, D. J., Harries, M. H., Southam, E., Jones, D. N. C., Dawson, L. A.

    Published in Psychopharmacology (01-01-2009)
    “…Rationale Positive allosteric modulators of the glutamatergic α-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor do not stimulate AMPA…”
    Get full text
    Journal Article
  3. 3

    Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity by Gartlon, J., Kinsner, A., Bal-Price, A., Coecke, S., Clothier, R.H.

    Published in Toxicology in vitro (01-12-2006)
    “…The European Commission White Paper, “Strategy for a future chemicals policy” (EC, 2001) is estimated to require the testing of approximately 30,000 ‘existing’…”
    Get full text
    Journal Article
  4. 4
  5. 5

    The effects of ziprasidone on regional c-Fos expression in the rat forebrain by JENNINGS, C. A, CLUDERAY, J. E, GARTLON, J, CILIA, J, LLOYD, A, JONES, D. N. C, SOUTHAM, E

    Published in Psychopharmacologia (2006)
    “…Typical and atypical antipsychotic drugs produce characteristic patterns of immediate early gene expression in rat forebrain that are considered to reflect…”
    Get full text
    Journal Article
  6. 6

    Central effects of urotensin-II following ICV administration in rats by GARTLON, Jane, PARKER, Frederick, HUNTER, Jackie A, JONES, Declan N. C, HARRISON, David C, DOUGLAS, Stephen A, ASHMEADE, Tracey E, RILEY, Graham J, HUGHES, Zoe A, TAYLOR, Stephen G, MUNTON, Richard P, HAGAN, Jim J

    Published in Psychopharmacologia (01-06-2001)
    “…Urotensin-II (U-II) has recently been identified as an agonist for the G-protein-coupled receptor, GPR14. Detection of both U-II and GPR14 mRNA in the brain…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Long-term behavioural, molecular and morphological effects of neonatal NMDA receptor antagonism by Wiseman Harris, Laura, Sharp, Trevor, Gartlon, Jane, Jones, Declan N. C., Harrison, Paul J.

    Published in The European journal of neuroscience (01-09-2003)
    “…Brief N‐methyl‐d‐aspartate (NMDA) receptor blockade in neonatal rats has been reported to increase neuronal apoptosis. We replicated this finding using MK‐801…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    Nitric oxide stimulates PC12 cell proliferation via cGMP and inhibits at higher concentrations mainly via energy depletion by Bal-Price, Anna, Gartlon, Joanne, Brown, Guy C.

    Published in Nitric oxide (01-05-2006)
    “…We investigated the mechanisms by which nitric oxide (NO) from an NO donor (DETA/NO) regulates proliferation of pheochromocytoma PC12 cells. The NO donor…”
    Get full text
    Journal Article
  12. 12

    The value of alternative testing for neurotoxicity in the context of regulatory needs by Coecke, Sandra, Eskes, Chantra, Gartlon, Joanne, Kinsner, Agnieszka, Price, Anna, van Vliet, Erwin, Prieto, Pilar, Boveri, Monica, Bremer, Susanne, Adler, Sarah, Pellizzer, Cristian, Wendel, Albrecht, Hartung, Thomas

    Published in Environmental toxicology and pharmacology (01-02-2006)
    “…Detection and characterisation of chemical-induced toxic effects in the central and peripheral nervous system represent a major challenge for employing newly…”
    Get full text
    Journal Article
  13. 13
  14. 14
  15. 15

    Development of a mechanistically-based genetically engineered PC12 cell system to detect p53-mediated cytotoxicity by van Vliet, Erwin, Eskes, Chantra, Stingele, Silvia, Gartlon, Joanne, Price, Anna, Farina, Massimo, Ponti, Jessica, Hartung, Thomas, Sabbioni, Enrico, Coecke, Sandra

    Published in Toxicology in vitro (01-06-2007)
    “…The human wild type p53 gene, key for apoptosis, was introduced into the pheochromocytoma (PC12) cell line, to create a mechanistically-based in vitro test…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    Effect of the selective dopamine D sub(3) receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain by Southam, E, Lloyd, A, Jennings, CA, Cluderay, JE, Cilia, J, Gartlon, JE, Jones, DNC

    Published in Brain research (14-05-2007)
    “…SB-277011-A is a dopamine D sub(3) receptor antagonist that exhibits over 100-fold selectivity over dopamine D sub(2) receptors and a broad spectrum of other…”
    Get full text
    Journal Article
  19. 19

    Urotensin-II, a neuropeptide ligand for GPR14, induces c- fos in the rat brain by Gartlon, Jane E., Ashmeade, Tracey, Duxon, Mark, Hagan, Jim J., Jones, Declan N.C.

    Published in European journal of pharmacology (16-06-2004)
    “…The vasoactive peptide urotensin-II and its receptor, GPR14 (now known as UT receptor), are localised in the mammalian central nervous system. Accordingly,…”
    Get full text
    Journal Article